PATENT CLAIM ANALYSIS

Application Number: 16176338
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "468000"]

Abstract:
The instant invention is generally directed to a patient-friendly drug delivery system for targeted populations, such as pediatric and geriatric patients. Specifically, the present invention relates to a pharmaceutical composition in the form of mini-tablets. Even more specifically, the present invention relates to a pharmaceutical composition comprising a therapeutically-effective amount of melatonin in the form of mini-tablets.

Claim (Index 3):
The controlled-release melatonin mini-tablet of  claim 1 , wherein the mini-tablet is formulated such that it produces a minimal blood level of about 60 to about 200 picograms melatonin per milliliter or about 100 to about 200 picograms melatonin per milliliter over at least four hours after oral ingestion of the controlled-release melatonin mini-tablet by a human patient.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 97.0
- Lexical Diversity: 1.575
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14482160', '12144453', '10269551', '14383462', '10895984']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7425823182089513
- 35 USC 102 Novelty (BERT): 0.518499485226813
- Combined Prediction Score: 0.7201740349107375
- Mean Citation Score: 230.050276
- Max Citation Score: 244.61156
- Similarity Product: 148.30658826296332

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test